Skip to main content
OpenTrials
Completed

NCT Number: NCT01727505

Volume Guarantee Ventilation in Preterm Infants With Frequent Episodes of Hypoxemia

Preterm infants undergoing mechanical ventilation often present with respiratory instability which leads to fluctuations in ventilation and oxygenation. In conventional modes of mechanical ventilation used in these patients, the ventilator delivers breaths at a set rate and a constant peak inspiratory pressure.

We have demonstrated that spontaneous episodes of hypoxemia in mechanically ventilated preterm infants are frequently triggered by a loss in end-expiratory lung volume followed by decrease in tidal volume. This is due to a reduction in respiratory system compliance and increase in airway resistance.

Volume Guarantee ventilation is a mode of ventilation in which ventilator measures the exhaled tidal volume of each ventilator breath and automatically adjusts the peak inspiratory pressure to deliver the set tidal volume. We have previously shown that Volume Guarantee reduced the severity and duration of hypoxemia episodes during a period of 2 hours in preterm infants The study hypothesis is that Volume Guarantee ventilation will decrease the duration of episodes of hypoxemia when compared to conventional mechanical ventilation during routine clinical conditions and over longer periods of time.

The objective of the study is to evaluate the effects of Volume Guarantee on the duration, severity and frequency of episodes of hypoxemia in mechanically ventilated preterm infants who present with frequent hypoxemia episodes in comparison to conventional ventilation over two periods of 24 hours each and under routine clinical conditions.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Newborn Intensitve Care Unit at Holtz Children's Hospital of Jackson Health System

Miami, Florida, 33136, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Born at less than 32 weeks of gestational age.
  • Requiring mechanical ventilation on a mandatory ventilator rate greater than or equal to 20 per minute and receiving a mean tidal volume of at least 4 ml/kg.
  • Presenting with 4 or more episodes of hypoxemia, defined as oxygen saturation less than 75%, in the 8 hours prior to the study.

Exclusion criteria

  • Major congenital anomalies.
  • Hemodynamic instability requiring inotropes within 72 hours prior to the study
  • Culture proven sepsis within 72 hours prior to the study.
  • Diagnosis of pulmonary interstitial emphysema or pneumothorax within the 72 hours prior to the study.

Treatment and study plan

Sequence A: Conventional-Volume Guarantee

Device

This is a crossover study. Infants will be randomly assigned to one of two sequences.

In sequence A, the infant will undergo a 24-hour period of conventional mechanical ventilation followed by a 24 hour period of volume guarantee ventilation.

Both conventional mechanical ventilation and volume guarantee ventilation will be provided by the same neonatal ventilator (AVEA, CareFusion Inc, Yorba Linda, CA).

During the 24 hour period of conventional mechanical ventilation, the infant will receive mechanical ventilation with the settings determined by the clinical team.

During volume guarantee ventilation, the set tidal volume to be maintained by the ventilator will be the average tidal volume delivered by the ventilator prior to start of study.

Sequence B: Volume Guarantee-Conventional

Device

This is a crossover study. Infants will be randomly assigned to one of two sequences.

In sequence B, the infant will undergo a 24-hour period of volume guarantee ventilation followed by a 24 hour period of conventional mechanical ventilation.

Both conventional mechanical ventilation and volume guarantee ventilation will be provided by the same neonatal ventilator (AVEA, CareFusion Inc, Yorba Linda, CA).

During the 24 hour period of conventional mechanical ventilation, the infant will receive mechanical ventilation with the settings determined by the clinical team.

During volume guarantee ventilation, the set tidal volume to be maintained by the ventilator will be the average tidal volume delivered by the ventilator prior to start of study.

Primary outcomes

  1. Percentage of Time Spent With Arterial Oxygen Saturation < 75%

    Time frame: 24 hours

    Percentage of time spent with arterial oxygen saturation < 75%

Secondary outcomes

  1. Frequency of Severe Hypoxemia Episodes

    Time frame: 24 hours

    Frequency of severe hypoxemia episodes defined as periods with arterial oxygen saturation SpO2 < 75% lasting for at least 20 seconds.

  2. Frequency of Hypoxemia Episodes

    Time frame: 24 hours

    Frequency of hypoxemia episodes defined as episodes with arterial saturation < 85% for at least 20 seconds

  3. Duration of Hypoxemia Episodes

    Time frame: 24 hours

    Duration of hypoxemia episodes of arterial saturation < 85% for at least 20 seconds. Calculated as the mean episode duration per subject per period. Reported as median and inter-quartile range of all subjects.

Other outcomes

  1. Fraction of Inspired Oxygen (FiO2)

    Time frame: 24 hours

    Calculated as the mean value of the recorded fraction of inspired oxygen for each subject during each of the two 24 hour periods.

    Reported as median and inter-quartile range of all subjects.

  2. Tidal Volume

    Time frame: 24 hours

    The mean exhaled tidal volume of mechanical breaths.

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Registry information

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Nov 16, 2012
Registry last updated
Mar 1, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.